Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CVRx, Inc.
The BAROSTIM NEO Hypertension Trial is a prospective, randomized, controlled trial assessing the safety and efficacy of the BAROSTIM NEO System in subjects with resistant hypertension.
All subjects are now in long term follow-up and are required to have at least one annual visit.
Parameters assessed during visits are:
* Office Cuff Blood Pressure
* Physical Assessment
* Subject Medications
* Serious adverse events
Age
21–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Actively participating in the Barostim Hypertension Pivotal Trial and currently implanted with the BAROSTIM NEO device with the device turned ON.
Have signed a revised approved informed consent form for continued participation in this study.
You may not be if
Treating physician decision that the subject should not continue with therapy.